In last trading session, Tarsus Pharmaceuticals Inc (NASDAQ:TARS) saw 0.68 million shares changing hands with its beta currently measuring 1.10. Company’s recent per share price level of $36.85 trading at $2.22 or 6.41% at ring of the bell on the day assigns it a market valuation of $1.38B. That closing price of TARS’s stock is at a discount of -9.63% from its 52-week high price of $40.40 and is indicating a premium of 65.89% from its 52-week low price of $12.57. Taking a look at company’s average trading volume volume of 698.02K if we extend that period to 3-months.

Tarsus Pharmaceuticals Inc (NASDAQ:TARS) trade information

Upright in the green during last session for gaining 6.41%, in the last five days TARS remained trading in the green while hitting it’s week-highest on Friday, 05/03/24 when the stock touched $36.85 price level, adding 0.78% to its value on the day. Tarsus Pharmaceuticals Inc’s shares saw a change of 81.98% in year-to-date performance and have moved 15.01% in past 5-day. Tarsus Pharmaceuticals Inc (NASDAQ:TARS) showed a performance of 5.47% in past 30-days.

Tarsus Pharmaceuticals Inc (TARS) estimates and forecasts

Statistics highlight that Tarsus Pharmaceuticals Inc is scoring comparatively lower than the scores of other players of the relevant industry. The company added 153.96% of value to its shares in past 6 months, showing an annual growth rate of 8.01% while that of industry is 12.80. Apart from that, the company came raising its revenue forecast for fiscal year 2024.

Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -132.82% during past 5 years.

TARS Dividends

Tarsus Pharmaceuticals Inc is more likely to be releasing its next quarterly report between May 07 and May 13 and investors are confident in the company announcing better current-quarter dividends despite the fact that it has been facing issues arising out of mounting debt.